Roche Files Avastin EU Marketing Authorization Application For NSCLC
This article was originally published in The Pink Sheet Daily
Executive Summary
An sBLA for the oncologic in non-small cell lung cancer is already pending in the U.S.
You may also be interested in...
FDA Requests Additional Information Regarding Avastin Breast Cancer Application
Genentech says the agency is seeking additional information regarding progression-free survival.
Genentech Aims To Extend Avastin Duration Of Use
Physicians have been treating first-line colorectal cancer patients for less time than the product was used for in clinical trials, Exec VP Clark says.
With Winrevair Approved, Merck Has A Chance To Execute On CV Strategy
The activin signaling inhibitor sotatercept was approved by the US FDA for pulmonary arterial hypertension.